Spiny...No need to apologise, I took issue with both Provalis and more importantly Cholestech with regard to Metrika A1cNow and why they selected Glycosal, I think I posted their reply on the original thread. Further more you must agree that the selection of Glycosal by Abbott Laboratories on its own is a significant endorsement?
As I have previously mentioned existing and future competition is inevitable, however, the fact that Glycosal has been selected by three companies who's analytical skills and technical understanding far outway that of ours carries for me at least a lot of weight.